Market Closed -
Hong Kong S.E.
04:08:20 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
5.1
HKD
|
+0.99%
|
|
+7.14%
|
-32.98%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
25,176
|
37,747
|
66,685
|
35,854
|
51,750
|
21,578
|
21,578
|
-
|
Enterprise Value (EV)
1 |
26,702
|
39,027
|
65,022
|
32,830
|
48,884
|
31,614
|
14,831
|
13,851
|
P/E ratio
|
16.9
x
|
20.3
x
|
32.8
x
|
15.9
x
|
18.9
x
|
15.7
x
|
9.72
x
|
8.09
x
|
Yield
|
1.81%
|
1.33%
|
0.88%
|
1.79%
|
1.46%
|
2.75%
|
3.25%
|
3.55%
|
Capitalization / Revenue
|
2.86
x
|
3.64
x
|
5.88
x
|
2.73
x
|
3.8
x
|
2.39
x
|
1.53
x
|
1.35
x
|
EV / Revenue
|
3.03
x
|
3.77
x
|
5.73
x
|
2.5
x
|
3.59
x
|
2.39
x
|
1.05
x
|
0.87
x
|
EV / EBITDA
|
11.8
x
|
13.3
x
|
21.1
x
|
8.89
x
|
12.9
x
|
10.3
x
|
4.42
x
|
3.6
x
|
EV / FCF
|
18.7
x
|
28.3
x
|
36.5
x
|
17
x
|
31.4
x
|
6.57
x
|
7.19
x
|
5.6
x
|
FCF Yield
|
5.33%
|
3.53%
|
2.74%
|
5.89%
|
3.18%
|
15.2%
|
13.9%
|
17.9%
|
Price to Book
|
1.73
x
|
2.32
x
|
3.77
x
|
1.85
x
|
2.37
x
|
0.94
x
|
0.88
x
|
0.81
x
|
Nbr of stocks (in thousands)
|
4,522,332
|
4,522,332
|
4,522,332
|
4,522,332
|
4,570,632
|
4,570,632
|
4,570,632
|
-
|
Reference price
2 |
5.567
|
8.347
|
14.75
|
7.928
|
11.32
|
4.721
|
4.721
|
4.721
|
Announcement Date
|
3/27/19
|
3/30/20
|
3/30/21
|
3/29/22
|
3/30/23
|
3/26/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
8,809
|
10,364
|
11,345
|
13,152
|
13,619
|
13,229
|
14,147
|
15,975
|
EBITDA
1 |
2,270
|
2,929
|
3,079
|
3,691
|
3,784
|
3,082
|
3,352
|
3,852
|
EBIT
1 |
1,710
|
2,331
|
2,389
|
3,004
|
3,023
|
2,218
|
2,614
|
3,135
|
Operating Margin
|
19.41%
|
22.5%
|
21.05%
|
22.84%
|
22.2%
|
16.77%
|
18.47%
|
19.63%
|
Earnings before Tax (EBT)
1 |
1,775
|
2,247
|
2,496
|
2,842
|
3,318
|
2,369
|
2,638
|
3,196
|
Net income
1 |
1,473
|
1,845
|
2,030
|
2,245
|
2,723
|
2,002
|
2,195
|
2,646
|
Net margin
|
16.72%
|
17.8%
|
17.89%
|
17.07%
|
20%
|
15.13%
|
15.52%
|
16.56%
|
EPS
2 |
0.3300
|
0.4115
|
0.4500
|
0.5000
|
0.6000
|
0.4400
|
0.4857
|
0.5836
|
Free Cash Flow
1 |
1,424
|
1,379
|
1,780
|
1,933
|
1,557
|
2,372
|
2,063
|
2,474
|
FCF margin
|
16.17%
|
13.31%
|
15.69%
|
14.7%
|
11.43%
|
17.81%
|
14.58%
|
15.49%
|
FCF Conversion (EBITDA)
|
62.76%
|
47.08%
|
57.81%
|
52.38%
|
41.14%
|
71.61%
|
61.54%
|
64.23%
|
FCF Conversion (Net income)
|
96.71%
|
74.76%
|
87.68%
|
86.13%
|
57.17%
|
119.04%
|
93.98%
|
93.51%
|
Dividend per Share
2 |
0.1010
|
0.1110
|
0.1300
|
0.1420
|
0.1650
|
0.1300
|
0.1534
|
0.1677
|
Announcement Date
|
3/27/19
|
3/30/20
|
3/30/21
|
3/29/22
|
3/30/23
|
3/26/24
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
4,943
|
5,421
|
5,091
|
6,254
|
6,230
|
6,922
|
6,975
|
6,644
|
6,898
|
6,332
|
6,419
|
7,846
|
7,025
|
8,586
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
-
|
1,533
|
1,471
|
1,580
|
1,443
|
1,390
|
827.9
|
1,153
|
1,295
|
1,287
|
1,471
|
Operating Margin
|
-
|
-
|
-
|
-
|
24.6%
|
21.25%
|
22.64%
|
21.72%
|
20.15%
|
13.08%
|
17.97%
|
16.51%
|
18.31%
|
17.13%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
1,856
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
1,459
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
20.92%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.2100
|
0.2015
|
0.2200
|
0.2300
|
0.2700
|
0.2300
|
0.3200
|
0.2800
|
0.2700
|
0.1700
|
0.2300
|
0.2700
|
0.2600
|
0.3100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/28/19
|
3/30/20
|
8/26/20
|
3/30/21
|
8/27/21
|
3/29/22
|
8/22/22
|
3/30/23
|
9/18/23
|
3/26/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
1,526
|
1,279
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
1,663
|
3,023
|
2,866
|
5,991
|
6,746
|
7,727
|
Leverage (Debt/EBITDA)
|
0.6721
x
|
0.4368
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1,424
|
1,379
|
1,780
|
1,933
|
1,557
|
2,373
|
2,063
|
2,474
|
ROE (net income / shareholders' equity)
|
10.6%
|
12%
|
12%
|
12%
|
13.3%
|
10.4%
|
9.46%
|
9.99%
|
ROA (Net income/ Total Assets)
|
7.23%
|
7.33%
|
7.56%
|
7.7%
|
8.6%
|
6.3%
|
6.45%
|
6.75%
|
Assets
1 |
20,384
|
25,156
|
26,849
|
29,161
|
31,662
|
31,637
|
34,035
|
39,195
|
Book Value Per Share
2 |
3.210
|
3.600
|
3.910
|
4.280
|
4.790
|
5.030
|
5.390
|
5.830
|
Cash Flow per Share
2 |
0.4900
|
0.5200
|
0.6000
|
0.6700
|
-
|
0.7800
|
0.4700
|
0.6100
|
Capex
1 |
795
|
942
|
896
|
1,071
|
658
|
853
|
675
|
821
|
Capex / Sales
|
9.02%
|
9.09%
|
7.9%
|
8.14%
|
4.83%
|
6.4%
|
4.77%
|
5.14%
|
Announcement Date
|
3/27/19
|
3/30/20
|
3/30/21
|
3/29/22
|
3/30/23
|
3/26/24
|
-
|
-
|
Last Close Price
4.721
CNY Average target price
8.129
CNY Spread / Average Target +72.19% Consensus |
1st Jan change
|
Capi.
|
---|
| -32.98% | 2.98B | | +11.84% | 27.79B | | -15.97% | 2.52B | | +11.90% | 2.34B | | -1.11% | 1.91B | | -13.37% | 1.83B | | -7.78% | 1.39B | | -0.38% | 1.27B | | +13.51% | 1.12B | | +4.01% | 1.13B |
Medical Supplies
|